Literature DB >> 2172955

Efficiency of cytoplasmic delivery by pH-sensitive liposomes to cells in culture.

C J Chu1, J Dijkstra, M Z Lai, K Hong, F C Szoka.   

Abstract

The intracellular processing of pH-sensitive liposomes composed of cholesterylhemisuccinate (CHEMS) and dioleoylphosphatidylethanolamine (DOPE) by eukaryotic cell lines has been compared to non-pH-sensitive liposomes made of CHEMS and dioleoylphosphatidylcholine (DOPC). The pH-sensitive liposomes can deliver encapsulated fluorescent molecules [calcein, fluoresceinated dextran, fluoresceinated polypeptide, and diphtheria toxin A chain (DTA)] into the cytoplasm. Cytoplasmic delivery can be blocked in the presence of ammonium chloride or EDTA, indicating that the process requires a low-pH environment and the presence of divalent cations. Inhibition of cellular protein synthesis by DTA delivery from the pH-sensitive liposome is orders of magnitude greater than from the non-pH-sensitive liposome composition. The delivery of DTA into the cytoplasm by pH-sensitive liposomes is at least 0.01% of cell-associated liposomal DTA. There is no significant difference in the degradation rate of bovine serum albumin (BSA) or the rate of acidification of pH-sensitive dye, 8-hydroxy-1,3,6-pyrene-trisulfonate (HPTS), when delivered to cells in pH-sensitive and non-pH-sensitive liposomes. Thus the efficiency of cytoplasmic delivery is less than 10% of the cell-associated liposome contents, which is the smallest difference that can be detected by these two assays. Based upon the various assays used to measure liposome content disposition in the cell, we conclude that the efficiency of cytoplasmic delivery by the CHEMS/DOPE liposomes is greater than 0.01% and less than 10% of the cell-associated liposomal contents.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2172955     DOI: 10.1023/a:1015908831507

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  47 in total

Review 1.  Progress toward human gene therapy.

Authors:  T Friedmann
Journal:  Science       Date:  1989-06-16       Impact factor: 47.728

2.  pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules.

Authors:  R M Straubinger; N Düzgünes; D Papahadjopoulos
Journal:  FEBS Lett       Date:  1985-01-01       Impact factor: 4.124

3.  Preparation of unilamellar liposomes of intermediate size (0.1-0.2 mumol) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes.

Authors:  F Szoka; F Olson; T Heath; W Vail; E Mayhew; D Papahadjopoulos
Journal:  Biochim Biophys Acta       Date:  1980-10-02

4.  pH-induced destabilization of phosphatidylethanolamine-containing liposomes: role of bilayer contact.

Authors:  H Ellens; J Bentz; F C Szoka
Journal:  Biochemistry       Date:  1984-03-27       Impact factor: 3.162

5.  Liposomes as a means to introduce fragment A of diphtheria toxin into cells.

Authors:  V K Jansons; E A Panzner
Journal:  Biochim Biophys Acta       Date:  1983-11-23

6.  Stimulation of T-independent antibody responses by hapten-lipopolysaccharides without repeating polymeric structure.

Authors:  R R Skelly; P Munkenbeck; D C Morrison
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

7.  Specific enhancement of drug delivery to AKR lymphoma by antibody-targeted small unilamellar vesicles.

Authors:  K K Matthay; T D Heath; D Papahadjopoulos
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

8.  Cloned fragment of diphtheria toxin linked to T cell-specific antibody identifies regions of B chain active in cell entry.

Authors:  M Colombatti; L Greenfield; R J Youle
Journal:  J Biol Chem       Date:  1986-03-05       Impact factor: 5.157

9.  The use of a new radioactive-iodine labeled lipid marker to follow in vivo disposition of liposomes: comparison with an encapsulated aqueous space marker.

Authors:  R M Abra; H Schreier; F C Szoka
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1982-08

10.  Degradation of proteins microinjected into IMR-90 human diploid fibroblasts.

Authors:  N T Neff; L Bourret; P Miao; J F Dice
Journal:  J Cell Biol       Date:  1981-10       Impact factor: 10.539

View more
  29 in total

Review 1.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

2.  Enhanced pH-Responsiveness, Cellular Trafficking, Cytotoxicity and Long-circulation of PEGylated Liposomes with Post-insertion Technique Using Gemcitabine as a Model Drug.

Authors:  Hongtao Xu; James W Paxton; Zimei Wu
Journal:  Pharm Res       Date:  2015-02-06       Impact factor: 4.200

Review 3.  Biodegradable nanoparticles for cytosolic delivery of therapeutics.

Authors:  Jaspreet K Vasir; Vinod Labhasetwar
Journal:  Adv Drug Deliv Rev       Date:  2007-06-26       Impact factor: 15.470

4.  Cyclic amphipathic peptide-DNA complexes mediate high-efficiency transfection of adherent mammalian cells.

Authors:  J Y Legendre; F C Szoka
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

5.  Cytoplasmic delivery of liposomes into MCF-7 breast cancer cells mediated by cell-specific phage fusion coat protein.

Authors:  Tao Wang; Shenghong Yang; Valery A Petrenko; Vladimir P Torchilin
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

6.  Delivery of antibodies to the cytosol: debunking the myths.

Authors:  Andrea L J Marschall; Congcong Zhang; André Frenzel; Thomas Schirrmann; Michael Hust; Franck Perez; Stefan Dübel
Journal:  MAbs       Date:  2014-05-21       Impact factor: 5.857

7.  Bleomycin in octaarginine-modified fusogenic liposomes results in improved tumor growth inhibition.

Authors:  Alexander Koshkaryev; Aleksandr Piroyan; Vladimir P Torchilin
Journal:  Cancer Lett       Date:  2012-06-25       Impact factor: 8.679

8.  Docetaxel-loaded liposomes: preparation, pH sensitivity, pharmacokinetics, and tissue distribution.

Authors:  Hong Zhang; Rui-ying Li; Xia Lu; Zhen-zhen Mou; Gui-mei Lin
Journal:  J Zhejiang Univ Sci B       Date:  2012-12       Impact factor: 3.066

9.  Inhibition of the Friend retrovirus by antisense oligonucleotides encapsulated in liposomes: mechanism of action.

Authors:  C Ropert; C Malvy; P Couvreur
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

10.  Phosphatase-triggered fusogenic liposomes for cytoplasmic delivery of cell-impermeable compounds.

Authors:  J P Michael Motion; Juliane Nguyen; Francis C Szoka
Journal:  Angew Chem Int Ed Engl       Date:  2012-08-06       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.